We are live on ! Find out more
DA

Duality Advisers Portfolio holdings

AUM $1.01B
1-Year Est. Return 14.52%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+14.52%
3 Year Est. Return
-18.25%
5 Year Est. Return
10 Year Est. Return
AUM
$946M
AUM Growth
+$119M
Cap. Flow
+$43.2M
Cap. Flow %
4.57%
Top 10 Hldgs %
6.94%
Holding
780
New
249
Increased
144
Reduced
154
Closed
225

Top Buys

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$7.35M
2
XOM icon
ExxonMobil
XOM
+$6.97M
3
WMB icon
Williams Companies
WMB
+$6.69M
4
SNPS icon
Synopsys
SNPS
+$6.59M
5
UL icon
Unilever
UL
+$6.56M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$5.18M
2
PFE icon
Pfizer
PFE
+$5.16M
3
ABT icon
Abbott
ABT
+$5.06M
4
SJM icon
J.M. Smucker
SJM
+$4.86M
5
AMT icon
American Tower
AMT
+$4.86M

Sector Composition

Rank Sector Weight
1 Technology 16.74%
2 Financials 14.4%
3 Consumer Discretionary 14.21%
4 Industrials 12.5%
5 Healthcare 12.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSY icon
1
Hershey
HSY
$35.4B
$6.7M 0.71%
35,922
+10,670
+42% +$2.02M
ACGL icon
2
Arch Capital
ACGL
$36.1B
$6.68M 0.71%
+89,907
New +$7.35M
SNPS icon
3
Synopsys
SNPS
$71.5B
$6.64M 0.7%
+12,897
New +$6.59M
V icon
4
Visa
V
$677B
$6.64M 0.7%
25,503
+10,246
+67% +$2.53M
WMB icon
5
Williams Companies
WMB
$90.5B
$6.64M 0.7%
+190,539
New +$6.69M
XOM icon
6
ExxonMobil
XOM
$651B
$6.63M 0.7%
+66,321
New +$6.97M
UL icon
7
Unilever
UL
$131B
$6.63M 0.7%
+121,524
New +$6.56M
DVN icon
8
Devon Energy
DVN
$51.9B
$6.49M 0.69%
143,268
+39,453
+38% +$1.81M
PG icon
9
Procter & Gamble
PG
$343B
$6.28M 0.66%
42,859
+24,969
+140% +$3.7M
LLY icon
10
Eli Lilly
LLY
$1.07T
$6.28M 0.66%
10,774
+2,253
+26% +$1.32M
VRSN icon
11
VeriSign
VRSN
$25.3B
$6.15M 0.65%
29,874
+17,529
+142% +$3.65M
LEN icon
12
Lennar Class A
LEN
$20.4B
$6.13M 0.65%
+42,498
New +$5.12M
MCO icon
13
Moody's
MCO
$81.7B
$6.11M 0.65%
15,648
+7,822
+100% +$2.72M
TFC icon
14
Truist Financial
TFC
$63.2B
$6.09M 0.64%
164,920
+65,780
+66% +$2.07M
RACE icon
15
Ferrari
RACE
$63.3B
$6.05M 0.64%
17,878
+5,974
+50% +$1.99M
BAC icon
16
Bank of America
BAC
$435B
$5.76M 0.61%
171,159
+59,866
+54% +$1.74M
SYF icon
17
Synchrony
SYF
$23.7B
$5.73M 0.61%
150,098
+9,163
+7% +$290K
HOLX
18
DELISTED
Hologic
HOLX
$5.67M 0.6%
79,405
+54,744
+222% +$3.81M
MU icon
19
Micron Technology
MU
$1.04T
$5.62M 0.59%
+65,894
New +$4.9M
ZTS icon
20
Zoetis
ZTS
$31.6B
$5.58M 0.59%
28,282
+19,054
+206% +$3.37M
CCJ icon
21
Cameco
CCJ
$38.3B
$5.57M 0.59%
+129,299
New +$5.41M
RTX icon
22
RTX Corp
RTX
$287B
$5.57M 0.59%
66,232
+5,590
+9% +$442K
HUM icon
23
Humana
HUM
$46.7B
$5.55M 0.59%
+12,114
New +$5.97M
IEX icon
24
IDEX
IEX
$16.5B
$5.54M 0.59%
25,539
+12,593
+97% +$2.54M
WY icon
25
Weyerhaeuser
WY
$17.3B
$5.45M 0.58%
156,789
+66,250
+73% +$2.06M

Similar funds

Duality Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Duality Advisers held 780 positions worth $946M, up 14% from $827M the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Duality Advisers deployed $43.2M of net new capital in Q4 2023, opening 249 new positions and adding to 144 existing holdings. Its largest new stake was Arch Capital: 89,907 shares worth $6.68M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tapestry, an estimated $4.5M trimmed.

  • Duality Advisers's largest Q4 2023 buy was Arch Capital: 89,907 shares worth $6.68M.
  • Duality Advisers added most to Darden Restaurants in Q4 2023, an estimated $4.55M increase.
  • Duality Advisers's biggest Q4 2023 reduction was Tapestry, cutting an estimated $4.5M.
  • Duality Advisers fully exited Clorox in Q4 2023, selling an estimated $5.18M.
  • Duality Advisers's ten largest holdings make up 6.9% of its $946M portfolio in Q4 2023.
  • Duality Advisers opened 249 new positions and closed 225 in Q4 2023.
  • Duality Advisers's portfolio value rose 14% quarter-over-quarter to $946M.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.